Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Devilee

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|February 3, 2011
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patientsM A Didraga, E H van Beers, S A Joosse, et al.
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics ConsortiumP Devilee, J Hermans, J Eyfjörd, et al.
Human Pathology|October 22, 1998
Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fractionE M van Schothorst, M Beekman, P Torremans, et al.
Clinical Endocrinology|May 13, 2011
Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patientsE F Hensen, M D Siemers, J C Jansen, et al.
Clinical Genetics|February 26, 2011
High prevalence of founder mutations of the succinate dehydrogenase genes in the NetherlandsE F Hensen, N van Duinen, J C Jansen, et al.
European Journal of Human Genetics : EJHG|August 2, 2003
Possible consequences of applying guidelines to healthy women with a family history of breast cancerC J van Asperen, R A E M Tollenaar, E M M Krol-Warmerdam, et al.
Science (New York, N.Y.)|February 5, 2000
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paragangliomaB E Baysal, R E Ferrell, J E Willett-Brozick, et al.
Nature Genetics|March 1, 1996
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locusC M Phelan, T R Rebbeck, B L Weber, et al.
International Journal of Cancer|November 10, 2000
Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesisT Peelen, W de Leeuw, K van Lent, et al.
Journal of Medical Genetics|October 7, 2004
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantG H de Bock, M Schutte, E M M Krol-Warmerdam, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|February 3, 2011
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patientsM A Didraga, E H van Beers, S A Joosse, et al.
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics ConsortiumP Devilee, J Hermans, J Eyfjörd, et al.
Human Pathology|October 22, 1998
Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fractionE M van Schothorst, M Beekman, P Torremans, et al.
Clinical Endocrinology|May 13, 2011
Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patientsE F Hensen, M D Siemers, J C Jansen, et al.
Clinical Genetics|February 26, 2011
High prevalence of founder mutations of the succinate dehydrogenase genes in the NetherlandsE F Hensen, N van Duinen, J C Jansen, et al.
European Journal of Human Genetics : EJHG|August 2, 2003
Possible consequences of applying guidelines to healthy women with a family history of breast cancerC J van Asperen, R A E M Tollenaar, E M M Krol-Warmerdam, et al.
Science (New York, N.Y.)|February 5, 2000
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paragangliomaB E Baysal, R E Ferrell, J E Willett-Brozick, et al.
Nature Genetics|March 1, 1996
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locusC M Phelan, T R Rebbeck, B L Weber, et al.
International Journal of Cancer|November 10, 2000
Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesisT Peelen, W de Leeuw, K van Lent, et al.
Journal of Medical Genetics|October 7, 2004
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantG H de Bock, M Schutte, E M M Krol-Warmerdam, et al.
Pageof 12